International Journal of Pediatrics · 2018 · 10 citations · 11 references
Veterinary MedicinePediatricsPharmacologyNeonatal HealthNeonatologySepsisBiomarkers In SepsisNeonatal SepsisPediatric SepsisSepsis DiagnosisSepsis PathophysiologySepsis PrognosisBiomarker-based Sepsis DiagnosisBiomarker-based Sepsis PrognosticationNeonatal Sepsis DiagnosisPediatric Sepsis DiagnosisPositive Predictive ValuePrognostic Marker AssessmentPrognostic Marker EvaluationPrognostic Prediction
INTRODUCTION: To evaluate Proadrenomedullin (Pro-ADM) as the diagnostic and prognostic marker in neonatal sepsis. MATERIALS AND METHODS: In this cross-sectional study, Pro-ADM levels were estimated in 54 neonates with clinical sepsis and positive sepsis screen (cases) and 54 controls without clinical sepsis. Repeat Pro-ADM levels were estimated after 72 hours in cases. Pro-ADM levels were compared with the clinical outcome. RESULTS AND DISCUSSION: Median Pro-ADM levels in cases were 31.8 (IQR: 27.8-39.4) pmol/ml which was significantly higher than controls 5.1 (IQR; 3.1-7.7) pmol/ml. From the constructed ROC curve, a value of 14.5 pmol/ml was taken as the cut-off for sepsis. Pro-ADM had 100% sensitivity, specificity, and positive predictive values (PPV) in detecting sepsis at 14.5 pmol/ml. Among cases, a decrease in Pro-ADM level by 10 pmol/ml was associated with 99% survival. Pro-ADM value of 35 pmol/ml had 100% specificity and PPV in predicting mortality. CONCLUSION: Pro-ADM can be used as a single biomarker for detecting neonatal sepsis, predicting clinical outcome and prognosis.
11
Management of Neonates With Suspected or Proven Early-Onset Bacterial Sepsis
Richard A. Polin, L.A. Papile, Jill E. Baley et al. · PEDIATRICS · 2012 · 793 citations
Adrenomedullin, a Multifunctional Regulatory Peptide
J. P. Hinson · Endocrine Reviews · 2000 · 255 citations
Rubén Pı́o, Alfredo Martı́nez, Edward J. Unsworth et al. · Journal of Biological Chemistry · 2001 · 246 citations · Full text